Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases: 2023-2024

Historic Current Leases for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $186,000.

  • CG Oncology's Current Leases rose 305.33% to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $912,000, marking a year-over-year increase of 305.33%. This contributed to the annual value of $186,000 for FY2024, which is 14.29% down from last year.
  • As of FY2024, CG Oncology's Current Leases stood at $186,000, which was down 14.29% from $217,000 recorded in FY2023.
  • CG Oncology's 5-year Current Leases high stood at $217,000 for FY2023, and its period low was $186,000 during FY2024.
  • Its 2-year average for Current Leases is $201,500, with a median of $201,500 in 2023.
  • Data for CG Oncology's Current Leases shows a maximum YoY dropped of 14.29% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Current Leases stood at $217,000 in 2023, then fell by 14.29% to $186,000 in 2024.